Prostate Cancer - Results from #1280

Meta-analyses of mouse and human prostate single-cell transcriptomes reveal widespread epithelial plasticity in tissue regression, regeneration, and cancer. February 29, 2024

A prospective study of birth weight and prostate cancer risk and mortality in the Health Professionals Follow-up Study. February 28, 2024

Pencil Beam Scanning Proton Bragg Peak Conformal FLASH in Prostate Cancer Stereotactic Body Radiotherapy. February 28, 2024

Cancer cells employ lipid droplets to survive toxic stress. February 28, 2024

One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer. February 28, 2024

Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancer. February 28, 2024

Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk. February 28, 2024

Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS. February 27, 2024

Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING). February 27, 2024

Variation in communication of side effects in prostate cancer treatment consultations. February 27, 2024

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. February 27, 2024

Diffuse Pneumonitis after Lutetium-177-PSMA-617 Treatment in a Patient with Metastatic Castration-Resistant Prostate Cancer. February 27, 2024

Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1). February 27, 2024

Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer. February 26, 2024

Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis. February 26, 2024

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications. February 26, 2024

A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer. February 26, 2024

Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5. February 26, 2024

A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group. February 23, 2024

Addressing controversial areas in the management of advanced prostate cancer in Canada: Areas of consensus and controversy from the third Canadian consensus forum. February 23, 2024

Page 65 of 1435